Multiple sclerosis Nervous System Diseases Multiple sclerosis
Conditions
Interventions
The intervention in the study is the evidence-based protocol. This protocol will be used to provide information about medication risks and benefits from findings in the literature, and the observation
Sponsors
Royal Holloway, University of London
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Diagnosis of relapsing-remitting multiple sclerosis (RRMS) by a consultant neurologist to best current criteria (i.e. not clinically isolated syndrome (CIS), likely Polman et al., 2011) 2. Able and willing to give informed consent 3. Able to meet tasks demands of study in terms of sensorimotor abilities 4. Ages 18 to 60
Exclusion criteria
Exclusion criteria: 1. Significant change in medication in last 4 weeks 2. Relapse recovery within last 4 weeks 3. Significant psychiatric history/condition 4. Significant medical condition (other than MS), personal or social circumstances likely to influence study participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patients' decisional conflict, assessed using the Decisional Conflict Scale directly after each condition (i.e. four times in total) | — |
Secondary
| Measure | Time frame |
|---|---|
| Patients' understanding of the information provided during the study, assessed using an author-designed questionnaire directly after each condition (i.e. four times in total) | — |
Countries
United Kingdom
Contacts
Public ContactGurpreet Reen
Outcome results
None listed